Compounds for the treatment of alzheimer's disease

Details Compounds for the treatment of alzheimer's disease Compounds for the treatment of alzheimer's disease

C - Chemistry, Metallurgy

07

D

C07D 277/28 (2006.01) A61K 31/381 (2006.01) A61K 31/415 (2006.01) A61K 31/426 (2006.01) A61K 31/4406 (2006.01) A61K 31/4439 (2006.01) A61K 31/549 (2006.01) A61P 25/00 (2006.01) C07D 213/40 (2006.01) C07D 231/12 (2006.01) C07D 333/20 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2618019

The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1 to R13, A, B, L, and i are defined as indicated in the description and the claims, as well as the use thereof for treating Alzheimer's disease (AD) and similar diseases.

La présente invention concerne des 1,2-éthylènediamines de formule générale (I) dans laquelle les radicaux R1 à R13, A, B, L et i sont tels que définis dans la description et les revendications, et l'utilisation desdites substances pour traiter la maladie d'Alzheimer (AD) et des pathologies similaires.

Affiliated with

Also associated with

Rating

Compounds for the treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for the treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for the treatment of alzheimer's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1375144